Mesoblast (MESO) - 2023 Q1 - Quarterly Report
Mesoblast (MESO)2022-08-31 10:36Exhibit 99.1 MESOBLAST REPORTS FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS FOR FISCAL YEAR ENDED JUNE 30, 2022 Melbourne, Australia; August 31 and New York, USA; August 30, 2022: Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today reported financial results and operational highlights for the period ended June 30, 2022 and provided an update on upcoming milestones. "I am pleased to report that calendar year 2022 is shaping up to be a tran ...